Southland Equity Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Buy
2,154
+317
+17% +$37.1K 0.05% 247
2026
Q1
$221K Buy
+1,837
New +$212K 0.04% 252
2024
Q3
Sell
-1,768
Closed -$219K 232
2024
Q2
$219K Buy
1,768
+2
+0.1% +$258 0.06% 191
2024
Q1
$233K Buy
+1,766
New +$218K 0.07% 191

Other funds holding MRK

Southland Equity Partners's MRK Position: Q2 2026 in Review

Southland Equity Partners increased its Merck (MRK) stake by 17% in Q2 2026, buying an estimated $37.1K and bringing the position to 2,154 shares worth $277K. The position accounts for 0.05% of the portfolio, ranked #247.

Southland Equity Partners first reported a position in MRK in Q1 2024 and has held it in 4 quarters since. 1,561 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Southland Equity Partners held 2,154 shares of Merck worth $277K as of Q2 2026.
  • Southland Equity Partners bought 317 Merck shares in Q2 2026, an estimated $37.1K.
  • Merck made up 0.05% of Southland Equity Partners's portfolio in Q2 2026, its #247 holding.
  • Southland Equity Partners first reported a position in Merck in Q1 2024 and has held it in 4 quarters since.
  • 1,561 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.